in the prevention and treatment of influenza in children during the 2025–2026 influenza season. A review of the evidence supporting these recommendations is in the accompanying technical report https://doi.org/10.1542/peds.2025-073622).
This statement updates the recommendations of the American Academy of Pediatrics (AAP) for the use of influenza vaccines and antiviral medications
in the prevention and treatment of influenza in children during the 2025–2026 influenza season. A review of the evidence supporting these recommendations is in the accompanying technical report https://doi.org/10.1542/peds.2025-073622).